Badania
Edukacja
Rozwiązania
PL
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Türkçe
JA - 日本語
PL - Polski
RU - Русский
HE - עִברִית
AR - العربية
Zaloguj się
Institute of Bioengineering and Swiss Institute of Experimental Cancer Research (ISREC)
Manuel Fankhauser has not added Biography.
If you are Manuel Fankhauser and would like to personalize this page please email our Author Liaison for assistance.
TIL therapy broadens the tumor-reactive CD8(+) T cell compartment in melanoma patients.
Oncoimmunology Jul, 2012 | Pubmed ID: 22754759
A catalytically inactive mutant of the deubiquitylase YOD-1 enhances antigen cross-presentation.
Blood Feb, 2013 | Pubmed ID: 23243279
École Polytechnique Fédérale de Lausanne
Esra Güç*,1,
Manuel Fankhauser*,1,
Amanda W. Lund1,2,
Melody A. Swartz1,
Witold W. Kilarski1
1Institute of Bioengineering and Swiss Institute of Experimental Cancer Research (ISREC), École Polytechnique Fédérale de Lausanne,
2Department of Cell and Developmental Biology and Knight Cancer Institute, Oregon Health & Science University
Prywatność
Warunki Korzystania
Zasady
Skontaktuj Się z Nami
Poleć Bibliotece
BIULETYNY JoVE
JoVE Journal
Methods Collections
JoVE Encyclopedia of Experiments
Archiwum
JoVE Core
JoVE Science Education
JoVE Lab Manual
JoVE Business
JoVE Quiz
JoVE Playlist
Autorzy
Bibliotekarze
Dostęp
O JoVE
JoVE Sitemap
Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone